YBX2
Y-box-binding protein 2
Also known as: Contrin, CSDA3, MSY2, YBOX2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2T7
- Gene
- YBX2
- Ensembl
- ENSG00000006047
- Chromosome
- 17
- Canonical length
- 364 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene encodes a nucleic acid binding protein which is highly expressed in germ cells. The encoded protein binds to a Y-box element in the promoters of certain genes but also binds to mRNA transcribed from these genes. Pseudogenes for this gene are located on chromosome 10 and 15. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q9Y2T7|YBX2
1 MSEVEAAAGA TAVPAATVPA TAAGVVAVVV PVPAGEPQKG GGAGGGGGAA SGPAAGTPSA
61 PGSRTPGNPA TAVSGTPAPP ARSQADKPVL AIQVLGTVKW FNVRNGYGFI NRNDTKEDVF
121 VHQTAIKRNN PRKFLRSVGD GETVEFDVVE GEKGAEATNV TGPGGVPVKG SRYAPNRRKS
181 RRFIPRPPSV APPPMVAEIP SAGTGPGSKG ERAEDSGQRP RRWCPPPFFY RRRFVRGPRP
241 PNQQQPIEGT DRVEPKETAP LEGHQQQGDE RVPPPRFRPR YRRPFRPRPR QQPTTEGGDG
301 ETKPSQGPAD GSRPEPQRPR NRPYFQRRRQ QAPGPQQAPG PRQPAAPETS APVNSGDPTT
361 TILELocalizationUniProt · AlphaFold · HPA
Whether an antibody against YBX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 493 nTPM
Expression across tissuesHPA
Tissue
- testis: 493 nTPM
- colon: 5.6 nTPM
- small intestine: 3 nTPM
- adipose tissue: 2.7 nTPM
- breast: 2.7 nTPM
- cerebral cortex: 2.6 nTPM
Single-cell type
- late spermatids: 126 nCPM
- late primary spermatocytes: 120 nCPM
- early spermatids: 85 nCPM
- early primary spermatocytes: 30 nCPM
- paneth cells: 3.9 nCPM
- undifferentiated spermatogonia: 3.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 2.8 nTPM
- medulla oblongata: 2 nTPM
- thalamus: 2 nTPM
- hippocampal formation: 1.9 nTPM
- white matter: 1.7 nTPM
- midbrain: 1.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about YBX2.
Disease | ImmuneIEDB
Conditions an epitope on YBX2 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.15
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- oocyte development
- positive regulation of cold-induced thermogenesis
- regulation of gene expression
- spermatogenesis
- transcription by RNA polymerase II
- translational attenuation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of YBX2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads YBX2 as an antibody target. Whether an autoantibody or antibody against YBX2 could matter depends on whether native YBX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
YBX2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label YBX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...